Macular Degeneration & Central Visual Loss
Assess distortion and central blur, recognise active disease and support useful vision.
20 learning units • 100 chapter sections • 200 explained questions. Assess visual symptoms, recognise sight-threatening disease and plan safe treatment, referral and follow-up.
Assess distortion and central blur, recognise active disease and support useful vision.
Quick revision ↓ Medical Dictionary
Difficulty reading, recognising faces or seeing straight lines clearly suggests central visual dysfunction. Test each eye because the better eye may mask change. Measure acuity and assess the macula through an appropriate examination. Cataract and refractive error can also cause blur, but new distortion particularly requires consideration of macular pathology.
Age-related macular degeneration affects central retinal function. Drusen and pigmentary changes may be seen in earlier stages; advanced disease can involve atrophy or neovascular complications. Not every druse means imminent severe loss. Explain findings in relation to stage and risk, avoiding both false reassurance and a prediction of inevitable blindness.
New central distortion, a central scotoma or rapid deterioration may indicate active neovascular AMD. Arrange urgent macular assessment through the local pathway. OCT and other investigations help identify activity and guide treatment. Do not postpone referral solely to try a new spectacle prescription when symptoms suggest recent macular change.
Intravitreal anti-VEGF therapy has an important role in active neovascular disease when appropriate. The specialist team determines the agent and treatment interval. Supplements are suitable only for selected AMD stages after professional advice, not as a universal cure. Smoking cessation and appropriate general health support remain valuable alongside eye-specific management.
Vision rehabilitation can improve function using magnification, lighting, contrast and accessible technology. Ask about reading, cooking, mobility and emotional impact. Explain monitoring advice and what constitutes a new change. A reassuring self-check does not replace scheduled assessment, and persistent new symptoms require review even when the person cannot describe a precise field defect.
Read the relevant guideline sections alongside these original clinical teaching cases. Local pathways, available services and individual patient factors determine care.
Reference review: 28 September 2026. Consult current local protocols for prescribing, procedures and escalation.